J9332 HCPCS code: Injection, efgartigimod alfa-fcab, 2mg
J9332 is the HCPCS Level II code for injection, efgartigimod alfa-fcab, 2mg. In 2024 Medicare paid an average of $25.04 per service for J9332 across 6,772,896 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 600 per day on outpatient hospital claims. Medicare volume rose 319% from 2022 to 2024 (1,617,563 to 6,772,896 services). In 2024, about 1,123 clinicians billed Medicare for J9332 for 938 beneficiaries; Florida, Texas, Illinois accounted for 31% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1D — Chemotherapy |
| Added | 2022-07-01 |
| Last action effective | 2022-07-01 |
Who bills J9332 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 1,123 |
| Medicare beneficiaries | 938 |
| States with claims | 29 |
| Share of services in top 3 states (Florida, Texas, Illinois) | 31% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J9332, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 1,617,563 | 497 | $30.54 | $24.33 |
| 2023 | 5,090,530 | 889 | $31.03 | $24.72 |
| 2024 | 6,772,896 | 938 | $31.44 | $25.04 |
States with the most J9332 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Florida | 876,345 | $25.24 |
| Texas | 676,596 | $25.20 |
| Illinois | 411,018 | $25.27 |
| South Carolina | 380,591 | $25.24 |
| North Carolina | 355,420 | $25.21 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 600 | Prescribing Information |
| practitioner claims | 600 | Prescribing Information |
What changed for J9332
- 2022-07-01: J9332 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J9332?
J9332 is the HCPCS Level II code for injection, efgartigimod alfa-fcab, 2mg. Short descriptor: "Inj efgartigimod 2mg".
How much does Medicare pay for J9332?
In 2024, the average Medicare payment was $25.04 per service (average allowed $31.44).
Does Medicare cover J9332?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
How many units of J9332 can be billed per day?
600 on outpatient hospital claims; 600 on practitioner claims (NCCI medically unlikely edits).
Related J93 codes
- J9300 — Injection, gemtuzumab ozogamicin, 5 mg
- J9301 — Injection, obinutuzumab, 10 mg
- J9302 — Injection, ofatumumab, 10 mg
- J9303 — Injection, panitumumab, 10 mg
- J9304 — Injection, pemetrexed (pemfexy), 10 mg
- J9305 — Injection, pemetrexed, not otherwise specified, 10 mg
- J9306 — Injection, pertuzumab, 1 mg
- J9307 — Injection, pralatrexate, 1 mg
- J9308 — Injection, ramucirumab, 5 mg
- J9309 — Injection, polatuzumab vedotin-piiq, 1 mg
- J9310 — Injection, rituximab, 100 mg
- J9311 — Injection, rituximab 10 mg and hyaluronidase
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J9332
- Watch J9332 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J9332
Sources: CMS HCPCS Level II release October 2025; CMS DMEPOS fee schedule; CMS NCCI MUE tables; CMS Medicare utilization (physician and DME supplier files); CMS Medicare Coverage Database articles. Fees are Medicare allowables, not commercial rates. Not billing or legal advice.